About Sweta Vijayan
Sweta holds a degree in Economics. Her fundamental approach in analyzing different financial instruments helps investors identify untapped investment opportunities.
Recent Articles By Sweta Vijayan
Alight vs. Workday: Which Stock is a Better Investment?
The rising demand for secure and efficient cloud platforms should benefit Workday (WDAY) and Alight (ALIT). But which of these stocks is a better buy now? Let’s find out.
American Express vs. Discover Financial Services: Which Credit Card Stock is a Better Investment?
The economic recovery and rising consumer spending and are driving the credit card industry’s growth. Therefore, credit card giants American Express (AXP) and Discover Financial (DFS) should benefit. But which of these stocks is a better buy now? Let’s find out.
Couchbase vs. Cloudera: Which Data Management Stock is a Better Buy?
Surging demand for efficient and secure real-time data management platforms from enterprises amid the ongoing remote working trend should benefit Cloudera (CLDR) and Couchbase (BASE). But which of these stocks is a better buy now? Let’s find out.
4 Top Healthcare Stocks to Buy in September
The ongoing integration of advanced technologies and significant breakthroughs therein, along with rising capital investments and an aging population, make the healthcare industry’s prospects bright. Therefore, we think quality healthcare stocks GlaxoSmithKline (GSK), Zoetis (ZTS), Mettler-Toledo (MTD), and Smith & Nephew (SNN) could be ideal bets now. Read on.
Sonim Technologies vs. Nokia: Which Ultra-Rugged Mobile Phone Manufacturer is a Better Choice?
The demand for ultra-rugged phones has grown in recent years, given their durability compared to regular phones. This growing demand should incentivize makers of these phones to upgrade user interfaces and manufacture 5G-enabled devices to offer a better user experience. We think both Nokia (NOK) and Sonim Technologies (SONM) should benefit from the sector tailwinds. But which of these stocks is a better buy now? Let’s find out.
Avoid These 3 Biotech Stocks That Were Recently Downgraded
The biotech industry is making considerable progress in developing viable drugs and therapies for treating several critical diseases with the integration of advanced technologies. But although rising investments and breakthroughs in clinical trials make the industry’s prospects bright, Genmab (GMAB), argenx (ARGX), and XOMA (XOMA) are not well-positioned to capitalize on the tailwinds. As a result, analysts have recently downgraded these stocks. Let’s discuss.
4 Top Tech Hardware Stocks to Own in September
Continued remote working and digital transformation should drive the demand for computer hardware. Hence, fundamentally sound stocks in this space, Dell Technologies (DELL), Canon (CAJ), Toshiba (TOSYY), and Lenovo (LNVGY), are expected to deliver solid returns in the coming months. So, let’s discuss these names.
Shake Shack vs. Papa John's: Which Restaurant Stock is a Better Buy?
Restaurants are focusing increasingly on digitizing their operations and offering contactless delivery services to meet the challenges of rising COVID-19 cases. Also, booster vaccine shots and rising consumer spending are among the factors that should help Papa John's (PZZA) and Shake Shack (SHAK) endure. But which of these stocks is a better buy now? Let’s find out.
4 Energy Stocks at or below $10 to Buy Now
Because the energy industry is thriving on rising oil prices, the shares of mega players that are currently trading at expensive valuations might witness a price decline with a gradual increase in supply capping oil prices and anticipated pressure on the stock market. Therefore, we think it could be wise to invest in low-priced energy stocks Archrock (AROC), VAALCO Energy (EGY), Amplify Energy (AMPY), and Geospace Technologies (GEOS). These companies have the potential to capitalize on industry tailwinds and deliver better returns in the coming months. Let’s discuss.